Clinical trial NCT00411736 - References

Cystic Fibrosis — Scandinavian Cystic Fibrosis Azithromycin Study

Citation(s)

•   Döring G, Conway SP, Heijerman HG, Hodson ME, Høiby N, Smyth A, Touw DJ
  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000 Oct;16(4):749-67. Review.
•   Equi A, Balfour-Lynn IM, Bush A, Rosenthal M
  Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet. 2002 Sep 28;360(9338):978-84.
•   Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski BH
  Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2005 Sep;49(9):3858-67.
•   Hansen CR, Pressler T, Koch C, Høiby N
  Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. J Cyst Fibros. 2005 Mar;4(1):35-40.
•   Høiby N, Frederiksen B, Pressler T
  Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005 Aug;4 Suppl 2:49-54. Review.
•   Jaffé A, Francis J, Rosenthal M, Bush A
  Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet. 1998 Feb 7;351(9100):420.
•   Kobayashi H
  Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. Am J Med. 1995 Dec 29;99(6A):26S-30S.
•   Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW 3rd; Macrolide Study Group
  Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003 Oct 1;290(13):1749-56.
•   Valerius NH, Koch C, Høiby N
  Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991 Sep 21;338(8769):725-6.
•   Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J
  Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax. 2002 Mar;57(3):212-6.

Supplementary Oral Azithromycin in Treatment of Intermittent Pseudomonas Aeruginosa Colonization in CF-patients With Inhaled Colistin and Oral Ciprofloxacin; Postponing Next Isolate of Pseudomonas and Prevention of Chronic Infection. A Prospective, Double-blinded, Placebo-controlled Scandinavian Multi-centre Study.

Details for clinical trial NCT00411736